Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC v1.0 BeadChip microarrays
DNA methylation (DNAm) plays a crucial role in a number of complex diseases. However, the reliability of DNAm levels measured using Illumina arrays varies across different probes. Previous research primarily assessed probe reliability by comparing duplicate samples between the 450k-450k or 450k-EPIC platforms, with limited investigations on Illumina EPIC v1.0 arrays. We conducted a comprehensive assessment of the EPIC v1.0 array probe reliability using 69 blood DNA samples, each measured twice, generated by the Alzheimer's Disease Neuroimaging Initiative study. We observed higher reliability in probes with average methylation beta values of 0.2 to 0.8, and lower reliability in type I probes or those within the promoter and CpG island regions. Importantly, we found that probe reliability has significant implications in the analyses of Epigenome-wide Association Studies (EWAS). Higher reliability is associated with more consistent effect sizes in different studies, the identification of differentially methylated regions (DMRs) and methylation quantitative trait locus (mQTLs), and significant correlations with downstream gene expression. Moreover, blood DNAm measurements obtained from probes with higher reliability are more likely to show concordance with brain DNAm measurements. Our findings, which provide crucial reliability information for probes on the EPIC v1.0 array, will serve as a valuable resource for future DNAm studies.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Epigenetics - 19(2024), 1 vom: 15. Apr., Seite 2333660 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Wei [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
DNA methylation |
|---|
| Anmerkungen: |
Date Completed 04.04.2024 Date Revised 15.04.2024 published: Print-Electronic UpdateOf: Res Sq. 2023 Oct 17;:. - PMID 37461726 Citation Status MEDLINE |
|---|
| doi: |
10.1080/15592294.2024.2333660 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370542045 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370542045 | ||
| 003 | DE-627 | ||
| 005 | 20240415233634.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240404s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/15592294.2024.2333660 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM370542045 | ||
| 035 | |a (NLM)38564759 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Wei |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC v1.0 BeadChip microarrays |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a UpdateOf: Res Sq. 2023 Oct 17;:. - PMID 37461726 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a DNA methylation (DNAm) plays a crucial role in a number of complex diseases. However, the reliability of DNAm levels measured using Illumina arrays varies across different probes. Previous research primarily assessed probe reliability by comparing duplicate samples between the 450k-450k or 450k-EPIC platforms, with limited investigations on Illumina EPIC v1.0 arrays. We conducted a comprehensive assessment of the EPIC v1.0 array probe reliability using 69 blood DNA samples, each measured twice, generated by the Alzheimer's Disease Neuroimaging Initiative study. We observed higher reliability in probes with average methylation beta values of 0.2 to 0.8, and lower reliability in type I probes or those within the promoter and CpG island regions. Importantly, we found that probe reliability has significant implications in the analyses of Epigenome-wide Association Studies (EWAS). Higher reliability is associated with more consistent effect sizes in different studies, the identification of differentially methylated regions (DMRs) and methylation quantitative trait locus (mQTLs), and significant correlations with downstream gene expression. Moreover, blood DNAm measurements obtained from probes with higher reliability are more likely to show concordance with brain DNAm measurements. Our findings, which provide crucial reliability information for probes on the EPIC v1.0 array, will serve as a valuable resource for future DNAm studies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a DNA methylation | |
| 650 | 4 | |a EPIC v1.0 array | |
| 650 | 4 | |a probe reliability | |
| 700 | 1 | |a Young, Juan I |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez, Lissette |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt, Michael A |e verfasserin |4 aut | |
| 700 | 1 | |a Lukacsovich, David |e verfasserin |4 aut | |
| 700 | 1 | |a Varma, Achintya |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, X Steven |e verfasserin |4 aut | |
| 700 | 1 | |a Kunkle, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Martin, Eden R |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Lily |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Epigenetics |d 2006 |g 19(2024), 1 vom: 15. Apr., Seite 2333660 |w (DE-627)NLM16994431X |x 1559-2308 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:1 |g day:15 |g month:04 |g pages:2333660 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/15592294.2024.2333660 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 1 |b 15 |c 04 |h 2333660 | ||